Helicon Health cited in NICE Guidelines on Atrial Fibrillation

Helicon Health’s web based package of services – HeliconHeart – is cited as an example of good practice in the new NICE Guidelines on Atrial Fibrillation (AF), which were published on 18 June 2014.

Atrial fibrillation is the most common sustained cardiac arrhythmia.  It affects some 800,000 patients in the UK alone.  Estimates suggest its prevalence is increasing and there may be as many as 250,000 patients undiagnosed.  If left untreated, atrial fibrillation is a significant risk factor for stroke and other morbidities.

HeliconHeart is a unique package of web-based services, tailored to assist the management of patients with atrial fibrillation who, typically, need both anticoagulation to reduce the risk of stroke and other measures to control the heart rate and rhythm.  Helicon Health’s approach and business model are set out in Shared Learning, alongside the new NICE Guidelines on Atrial Fibrillation.

David Patterson, chief executive, Helicon Health commented:

“We are delighted that our approach to meeting the needs of patients with AF has been recognized in this way.  Helicon Heart covers all elements of the NICE guidelines on AF so we are well placed to meet the needs of healthcare providers as they shape their anticoagulation services and work towards the better management of patients with AF.”

In addition to meeting the recommendations set out in the NICE Guidelines on AF, published today, HeliconHeart also complies with the NICE Guidelines – Support for commissioning: anticoagulation therapy, which were published in May 2013.

Further information:
[email protected]

More Helicon News

About the Author
David Patterson
David is a practising Consultant Physician and Cardiologist and Professor of Cardiovascular Medicine at UCL and the University of London.
Share this post
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share This